Seegene’s Q1 sales increased by nearly 30% with operating profit and net income turning positive. Diagnostic reagent sales accounted for 83.2 billion won, up 30.4% from the same period last year, with non-COVID diagnostic reagent sales growing by 37.5%. Sales were highest in Europe (64%), followed by Asia (15%), Korea (9%), Latin America (7%), and North America (4%).
Original Article: Read More
Auto-posted at: 2025-05-09 21:03:24